← Back to Search

Observational for Multiple Myeloma

N/A
Recruiting
Led By Shaji K. Kumar, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 3 months, up to 10 years
Awards & highlights

Study Summary

This study evaluates the outcomes of patients undergoing initial therapy for multiple myeloma.

Eligible Conditions
  • Multiple Myeloma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 3 months, up to 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 3 months, up to 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients have their medical records reviewed on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,764,714 Total Patients Enrolled
76 Trials studying Multiple Myeloma
7,341 Patients Enrolled for Multiple Myeloma
Shaji K. Kumar, M.D.Principal InvestigatorMayo Clinic in Rochester
8 Previous Clinical Trials
409 Total Patients Enrolled
8 Trials studying Multiple Myeloma
409 Patients Enrolled for Multiple Myeloma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1580 spots leftby Dec 2025